Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICAD
3626
DELISTED
iCAD Inc
ICAD
| $466K | ﹤0.01% |
220,814
+9,976
| +5% | +$23.7K |
|
|
CYT
3627
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $465K | ﹤0.01% |
163,537
+44,505
| +37% | +$123K |
|
3628
SurgePays
SURG
$5.35M
| $463K | ﹤0.01% |
98,881
-5,108
| -5% | -$26.5K |
|
3629
IZEA Worldwide
IZEA
$60.4M
| $460K | ﹤0.01% |
213,011
-9,832
| -4% | -$22.6K |
|
3630
PharmaCyte Biotech
PMCB
$6.18M
| $460K | ﹤0.01% |
219,110
+36
| +0% | +$92 |
|
3631
Biodesix
BDSX
$228M
| $459K | ﹤0.01% |
13,919
-4,559
| -25% | -$127K |
|
|
PPSI
3632
Pioneer Power Solutions
PPSI
$32.6M
| $459K | ﹤0.01% |
73,355
+30,600
| +72% | +$215K |
|
3633
AMREP Corp
AXR
$120M
| $457K | ﹤0.01% |
27,173
+323
| +1% | +$5.63K |
|
|
GAN
3634
DELISTED
GAN Ltd
GAN
| $454K | ﹤0.01% |
391,344
+5,894
| +2% | +$9.27K |
|
|
ADTH
3635
DELISTED
AdTheorent Holding Co
ADTH
| $454K | ﹤0.01% |
351,662
-28,400
| -7% | -$39K |
|
3636
Hycroft Mining Holding Corp
HYMC
$1.92B
| $454K | ﹤0.01% |
151,997
+4,216
| +3% | +$15.6K |
|
3637
Flotek Industries
FTK
$968M
| $454K | ﹤0.01% |
102,362
+94
| +0.1% | +$447 |
|
|
HLTH
3638
DELISTED
Cue Health Inc. Common Stock
HLTH
| $453K | ﹤0.01% |
1,025,047
+34,772
| +4% | +$15.9K |
|
3639
American Realty Investors
ARL
$253M
| $451K | ﹤0.01% |
30,829
-532
| -2% | -$10K |
|
3640
Pharvaris
PHVS
$2.25B
| $451K | ﹤0.01% |
21,595
+2,952
| +16% | +$54.4K |
|
3641
Personalis
PSNL
$1.41B
| $450K | ﹤0.01% |
371,898
+6,179
| +2% | +$11K |
|
3642
Auburn National Bancorp
AUBN
$91.7M
| $449K | ﹤0.01% |
20,792
+3,931
| +23% | +$85.5K |
|
3643
GSI Technology
GSIT
$233M
| $449K | ﹤0.01% |
165,636
-9,693
| -6% | -$37.6K |
|
|
SCRM
3644
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
| $447K | ﹤0.01% |
42,701
-20,006
| -32% | -$208K |
|
3645
Betterware México
BWMX
$639M
| $446K | ﹤0.01% |
27,400
+3,830
| +16% | +$57.6K |
|
|
FARM
3646
DELISTED
Farmer Brothers
FARM
| $443K | ﹤0.01% |
171,781
+7,882
| +5% | +$20.6K |
|
|
LCA
3647
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
| $442K | ﹤0.01% |
42,383
-1,036
| -2% | -$10.7K |
|
3648
Torrid Holdings
CURV
$264M
| $441K | ﹤0.01% |
199,631
-13,779
| -6% | -$31.9K |
|
|
ASTR
3649
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $437K | ﹤0.01% |
236,042
+150,196
| +175% | +$652K |
|
3650
Idaho Strategic Resources
IDR
$461M
| $437K | ﹤0.01% |
86,601
+5,020
| +6% | +$27.3K |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.